ABIONYX PHARMA EUR0.05ABIONYX PHARMA EUR0.05ABIONYX PHARMA EUR0.05

ABIONYX PHARMA EUR0.05

No trades
See on Supercharts
Market capitalization
‪33.98 M‬EUR
−0.118EUR
‪−3.50 M‬EUR
‪4.60 M‬EUR
‪30.66 M‬
Beta (1Y)
0.29

About ABIONYX PHARMA EUR0.05

CEO
Cyrille Tupin
Headquarters
Balma
Founded
2005
ISIN
FR0012616852
FIGI
BBG00JHW6Y35
ABIONYX Pharma SA engages in the in discovery and development of novel therapies for patients without existing or effective treatments. It specializes in the development of treatment for cardiovascular and metabolic disorders. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Balma, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0RAG is 1.094 EUR — it has increased by 10.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ABIONYX PHARMA EUR0.05 stocks are traded under the ticker 0RAG.
ABIONYX PHARMA EUR0.05 is going to release the next earnings report on Sep 26, 2024. Keep track of upcoming events with our Earnings Calendar.
0RAG stock is 9.43% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is ABIONYX PHARMA EUR0.05 there?
Yes, you can track ABIONYX PHARMA EUR0.05 financials in yearly and quarterly reports right on TradingView.
0RAG stock has risen by 10.41% compared to the previous week, the month change is a 15.67% rise, over the last year ABIONYX PHARMA EUR0.05 has showed a 40.27% decrease.
0RAG net income for the last quarter is ‪−1.25 M‬ EUR, while the quarter before that showed ‪−2.25 M‬ EUR of net income which accounts for 44.31% change. Track more ABIONYX PHARMA EUR0.05 financial stats to get the full picture.
Today ABIONYX PHARMA EUR0.05 has the market capitalization of ‪33.46 M‬, it has increased by 0.91% over the last week.
No, 0RAG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0RAG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABIONYX PHARMA EUR0.05 stock right from TradingView charts — choose your broker and connect to your account.
0RAG reached its all-time high on Jan 4, 2022 with the price of 3.266 EUR, and its all-time low was 0.374 EUR and was reached on May 24, 2019.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABIONYX PHARMA EUR0.05 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABIONYX PHARMA EUR0.05 stock shows the sell signal. See more of ABIONYX PHARMA EUR0.05 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ABIONYX PHARMA EUR0.05 future price: according to them, 0RAG price has a max estimate of 10.50 EUR and a min estimate of 10.50 EUR. Read a more detailed ABIONYX PHARMA EUR0.05 forecast: see what analysts think of ABIONYX PHARMA EUR0.05 and suggest that you do with its stocks.